Compass… updates on [synthetic polymorph] psilocybin…
Compass sinks after depression therapy results… the net loss for the year [2021] was $71.7 million…
…Compass doesn’t have any meaningful revenue… continues to explore… indications and therapeutic approaches… there were 12 people in the [synthetic psilocybin polymorph] study… who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves.
Original Article (Green Market Report & Bloomberg):
Compass gives updates on psilocybin research in earnings release & Compass sinks after depression therapy results fuel concerns
Artwork Fair Use: Audrius Meskauskas
Recent Comments